[{"AccountsPayableCurrent_0_Q1_USD":2865000.0,"ContractWithCustomerLiability_0_Q1_USD":3442000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":8531000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":139404000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q1_USD":8786000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-39000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"ContractualObligation_0_Q1_USD":23500000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"FinanceLeaseInterestExpense_1_Q1_USD":515000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-4706000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":121560000.0,"AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments_1_Q1_USD":-258000.0,"ProceedsFromSaleOfAvailableForSaleSecurities_1_Q1_USD":10606000.0,"ShortTermInvestments_0_Q1_USD":413869000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":47996000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-761000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":281000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":16916000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":11899000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":3723000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":89122000.0,"LongTermInvestments_0_Q1_USD":223000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":2532000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":143000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":16916000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":2729000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":0.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":517000.0,"FinanceLeaseLiability_0_Q1_USD":46941000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":12396000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":50621000.0,"OperatingLeaseCost_1_Q1_USD":309000.0,"OperatingLeaseLiability_0_Q1_USD":1578000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":678000.0,"OperatingLeasePayments_1_Q1_USD":149000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1658000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0475,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":1649000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1_Q1_USD":-439000.0,"OtherSundryLiabilitiesNoncurrent_0_Q1_USD":1357000.0,"OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities_1_Q1_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":5279000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":45900000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":24401000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"OtherAssetsCurrent_0_Q1_USD":2203000.0,"MoneyMarketFundsAtCarryingValue_0_Q1_USD":72148000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":689000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":12523000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":13883000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":13680000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":10535000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":3680000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":37017000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":2594000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0442,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-41224000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":24936000.0,"LeaseCost_1_Q1_USD":3126000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":1648000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":302000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":657000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":70000.0,"SubleaseIncome_1_Q1_USD":292000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":411363000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_1_Q1_USD":101000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":637000.0,"InventoryNet_0_Q1_USD":8408000.0,"Liabilities_0_Q1_USD":346748000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":824377000.0,"LiabilitiesCurrent_0_Q1_USD":66101000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-1190000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":30085000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":56009000.0,"NetIncomeLoss_1_Q1_USD":-78348000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":459000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":134028000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":7004000.0,"ProfitLoss_1_Q1_USD":-78348000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":40058000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-59486000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-3223000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-194000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-78542000.0,"AccountsReceivableNetCurrent_0_Q1_USD":58540000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1183000.0,"AdditionalPaidInCapital_0_Q1_USD":1319354000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8700000.0,"Assets_0_Q1_USD":824377000.0,"AssetsCurrent_0_Q1_USD":736405000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":121560000.0,"CommonStockSharesIssued_0_Q1_shares":88896000.0,"CommonStockSharesOutstanding_0_Q1_shares":88896000.0,"CommonStockValue_0_Q1_USD":889000.0,"Depreciation_1_Q1_USD":2868000.0,"DueFromRelatedPartiesCurrent_0_Q1_USD":126558000.0,"DueToRelatedPartiesCurrent_0_Q1_USD":92000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.89,"GainLossOnDispositionOfAssets_1_Q1_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-863068000.0,"StockholdersEquity_0_Q1_USD":458358000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":88219000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":42309000.0,"InventoryRawMaterials_0_Q1_USD":459000.0,"InventoryWorkInProcess_0_Q1_USD":2948000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":143283000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4608000.0,"PrepaidExpenseCurrent_0_Q1_USD":5267000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":477629000.0,"MinorityInterest_0_Q1_USD":19271000.0,"OtherAssetsNoncurrent_0_Q1_USD":8602000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q1_USD":9000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":5065000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-76418000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":1930000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":42309000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":34545000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":1649000.0,"InventoryFinishedGoods_0_Q1_USD":5001000.0,"AvailableForSaleSecurities_0_Q1_USD":414092000.0,"InterestAndOtherIncome_1_Q1_USD":3165000.0,"Cash_0_Q1_USD":49412000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockSharesAuthorized_0_Q1_shares":225000000.0,"InterestExpense_1_Q1_USD":633000.0,"OperatingExpenses_1_Q1_USD":105475000.0,"OperatingIncomeLoss_1_Q1_USD":-81074000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PreferredStockSharesAuthorized_0_Q1_shares":125000000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockValue_0_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":54902000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":49603000.0,"ShareBasedCompensation_1_Q1_USD":16916000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":103225000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1521000.0,"Supplies_0_Q1_USD":130000000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20200331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]